In people with T2D, 48% of the participants achieved 10% WL after 26 weeks of treatment with orforglipron 45 mg in a phase 2 trial (Fig
How Its Administered Sublingual (under the tongue): Held for 6090 seconds before swallowing for partial absorption into the bloodstream Oral (swallowed): Acts more locally in the stomach and intestines Dosage: Often ranges between 5001,000 mcg daily, depending on delivery and peptide strength Pros No injections required Easier to dose and travel with Potentially effective for ulcers, leaky gut, IBS, Crohns, and general GI inflammation Sublingual delivery may offer limited systemic absorption Cons Limited evidence supporting systemic efficacy Most research uses injectable models oral data is scarce Variable absorption depending on formulation and digestive environment May require higher or more frequent dosing to compensate for poor uptake Best For Individuals using BPC157 for gut health, intestinal permeability, or digestive inflammation Those who cant or wont inject peptides but still want potential healing benefits Stackers pairing oral BPC157 with systemic peptides (e.g., MK677) or gut support supplements BPC157 Capsules or Pills Capsule-based BPC157 supplements are increasingly marketed as convenient, over-the-counter alternatives to injectable or liquid forms
For OEM work, buyers often plan a two-step roadmap: first single-molecule Cagrilintide, then a dual-peptide option with GLP-1 once internal data looks stable
In Tasmania, peptides that are listed in Schedule 4 of the Poisons List are considered restricted substances under the Poisons Act 1971 (TAS)
